Cerity Partners’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Buy
88,090
+58,376
+196% +$1.33M ﹤0.01% 1532
2026
Q1
$636K Buy
29,714
+3,938
+15% +$82K ﹤0.01% 2138
2025
Q4
$551K Buy
25,776
+10,302
+67% +$211K ﹤0.01% 2034
2025
Q3
$259K Buy
+15,474
New +$232K ﹤0.01% 2376
2018
Q3
Sell
-10,364
Closed -$449K 555
2018
Q2
$449K Sell
10,364
-1,197
-10% -$57.4K 0.03% 349
2018
Q1
$643K Sell
11,561
-269
-2% -$14.7K 0.05% 296
2017
Q4
$632K Sell
11,830
-2
-0% -$94 0.04% 294
2017
Q3
$510K Buy
11,832
+98
+0.8% +$4.66K 0.04% 320
2017
Q2
$708K Buy
11,734
+19
+0.2% +$1.13K 0.06% 203
2017
Q1
$813K Buy
+11,715
New +$814K 0.07% 205

Other funds holding MD

Cerity Partners's MD Position: Q2 2026 in Review

Cerity Partners increased its Pediatrix Medical (MD) stake by 196% in Q2 2026, buying an estimated $1.33M and bringing the position to 88,090 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Cerity Partners first reported a position in MD in Q1 2017 and has held it in 10 quarters since. 285 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Cerity Partners held 88,090 shares of Pediatrix Medical worth $2.23M as of Q2 2026.
  • Cerity Partners bought 58,376 Pediatrix Medical shares in Q2 2026, an estimated $1.33M.
  • Pediatrix Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1532 holding.
  • Cerity Partners first reported a position in Pediatrix Medical in Q1 2017 and has held it in 10 quarters since.
  • 285 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.